Dataset Information

Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis.

ABSTRACT: Gasdermin D (GsdmD) was recently identified as the executioner of pyroptotic inflammatory cell death, and is a substrate for caspases-1 and 11. GsdmD is detrimental in lethal endotoxemia but protective in bacterial sepsis. However, little is known about its role during noninfectious/sterile injuries. In this study, we examined the contribution of GsdmD using WT and GsdmD^-/- mice in two models of noninfectious liver injury: hemorrhagic shock with resuscitation (HS/R) and acetaminophen (APAP) overdose. GsdmD^-/- mice had significantly increased liver damage at 6?h after HS/R or APAP vs WT, shown by significantly elevated ALT level and extended areas of cell death in liver. Caspase-8, a mediator of multiple cell death pathways, was highly elevated in GsdmD^-/- mice after injury. Significantly increased cleavage of caspase-8 and subsequent high levels of apoptosis were found in livers of GsdmD^-/- mice after HS/R, a relatively mild ROS-induced liver injury. However, during more severe APAP-mediated ROS-induced liver injury, caspase-8 cleavage in GsdmD^-/- liver was inhibited compared with WT, resulting in accumulation of pro-caspase-8 and increased levels of necroptosis. Our findings indicate a novel hepatoprotective role for GsdmD in noninfectious inflammation models via regulation of caspase-8 expression and downstream cell death pathways. The effects of GsdmD protection are likely injury specific and may also depend on injury severity and levels of ROS produced. These data suggest modulation of GsdmD/caspase-8 may be a novel therapeutic option in ROS-mediated liver injury.

SUBMITTER: Yang C

PROVIDER: S-EPMC6579760 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis.

Yang Chenxuan C Sun Ping P Deng Meihong M Loughran Patricia P Li Wenbo W Yi Zhongjie Z Li Shilai S Zhang Xianghong X Fan Jie J Billiar Timothy R TR Scott Melanie J MJ

Cell death & disease 20190617 7

Gasdermin D (GsdmD) was recently identified as the executioner of pyroptotic inflammatory cell death, and is a substrate for caspases-1 and 11. GsdmD is detrimental in lethal endotoxemia but protective in bacterial sepsis. However, little is known about its role during noninfectious/sterile injuries. In this study, we examined the contribution of GsdmD using WT and GsdmD<sup>-/-</sup> mice in two models of noninfectious liver injury: hemorrhagic shock with resuscitation (HS/R) and acetaminophen ...[more]

PMID: 31209224

Similar Datasets

Project description:To probe the binding sites of MeCbl on GSDME, 0.4 μM recombinant human GSDME (CSB-EP006766HU) purchased from CUSABIO (Wuhan, China) was incubated with 10 μM MeCbl in 100 μL buffer (20 mM HEPES, 150 mM NaCl and 50 μM DPA) at room temperature for 2 h and protected from light. 0.4 μM recombinant human GSDME was incubated with ddH2O as negative control, or with HOCbl for binding sites analysis between GSDME and cobalamin. All groups were equally prepared ten incubation samples and mixed for further analysis. Trypsin and Glu C were then added in the mixture overnight, and formic acid was added to adjust the pH down to three to terminate the enzyme digestion. Activated the C18 desalting column with 100 μL 100% acetonitrile, then centrifuged at 400 g for 3 min. Added 100 μL of 0.1% formic acid and centrifuged at 400 g for 3 min for column equilibration. Replaced with new EP tube, added samples to column, and centrifuged at 400 g for 3 min. Washed the column twice with 100 μL of 0.1% formic acid and centrifuged at 400 g for 3 min, washed once again with 100 μL water at pH10. The eluents were collected with 70% acetonitrile, each sample was lyophilized and stored at -80°C until further mass spectrometry analysis. Prepared the mobile phase solution, A (0.1% (v/v) formic acid in ddH2O), B (0.1% (v/v) formic acid and 80% acetonitrile in ddH2O), the lyophilized samples were dissolved with 10 µL solution A, then centrifuged at 14000 g for 20 min at 4°C, 400 ng supernatant of the samples were injected onto a Thermo Scientific™ UltiMate™ 3000 UHPLC coupled to a timsTOF HT mass spectrometer (BRUKER). Peptides were then separated over a 100 μm ⅹ15 cm ReproSil-Pur C18-AQ 1.5-µm silica beads (Beijing Qinglian Biotech Co.,Ltd, Beijing, China), at a flow rate of 300 nL/min using a gradient: 0-4 min (5-10% B), 4-46 min (10-24% B), 46-53 min (36% B), 53-54 min (95% B), 54-60 (95% B). The timsTOF HT mass spectrometer was used for liquid quality detection with Captive Spray source, and the mass spectrum was collected in DDA mode. The scanning range of the mass spectrum was m/z 100-1700, the primary mass spectrum resolution was set to 60,000 (1222 m/z), and the cumulative time was set to 100 ms in the TIMS tunnel. The capillary voltage is set at 1.6 kV and the mobility is 0.6-1.6 cm2/(V). The total cycle time was 1.1s with 10 PASEF cycles. The mass spectrometry raw data was processed by FragPipe to search against the target protein database. The precursor ion mass tolerance was ±15 ppm; the fragment mass tolerance was ±0.02 Da. The static modification was carbamidomethylation of cysteine; the dynamic modifications were oxidation of methionine, acetylation of N-termini of peptides and C63H91CoN13O14P or C62H88CoN13O14P of cysteine; a maximum of two missed cleavages were allowed.

Project description:Acute liver injury is a rapidly deteriorating clinical condition with markedly high morbidity and mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple bioactivities, and has therapeutic effects on various liver diseases. However, effects of OEA on acute liver injury remains unknown. In this study, effects and mechanisms of OEA in lipopolysaccharide (LPS)/d-galactosamine (D-Gal)-induced acute liver injury in mice were investigated. We found that OEA treatment significantly attenuated LPS/D-Gal-induced hepatocytes damage, reduced liver index (liver weight/body weight), decreased plasma alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) levels. Moreover, mechanism study suggested that OEA pretreatment significantly reduced hepatic MDA levels, increased Superoxide dismutase (SOD) and Glutathione peroxidase (GSH-PX) activities via up-regulate Nrf-2 and HO-1 expression to exert anti-oxidation activity. Additionally, OEA markedly reduced the expression levels of Bax, Bcl-2 and cleaved caspase-3 to suppress hepatocyte apoptosis. Meanwhile, OEA remarkedly reduced the number of activated intrahepatic macrophages, and alleviated the mRNA expression of pro-inflammatory factors, including TNF-α, IL-6, MCP1 and RANTES. Furthermore, OEA obviously reduced the expression of IL-1β in liver and plasma through inhibit protein levels of NLRP3 and caspase-1, which indicated that OEA could suppress NLRP3 inflammasome pathway. We further determined the protein expression of PPAR-α in liver and found that OEA significantly increase hepatic PPAR-α expression. In addition, HO-1 inhibitor ZnPP blocked the therapeutic effects of OEA on LPS/D-Gal-induced liver damage and oxidative stress, suggesting crucial role of Nrf-2/HO-1 pathway in the protective effects of OEA in acute liver injury. Together, these findings demonstrated that OEA protect against the LPS/D-Gal-induced acute liver injury in mice through the inhibition of apoptosis, oxidative stress and inflammation, and its mechanisms might be associated with the Nrf-2/HO-1 and NLRP3 inflammasome signaling pathways.

Dataset Information

Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis.

Publications

Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets